Neonatal hypertension
Check BP cuff, think renovascular · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Neonatal hypertension is blood pressure persistently above the gestational- and postnatal-age-specific 95th centile, most often secondary to renovascular (classically umbilical arterial catheter-associated thromboembolism), renal parenchymal, or cardiac/endocrine causes. After confirming accurate measurement, treatment is tailored to severity, with controlled reduction to avoid cerebral injury.
Red flags
- Encephalopathy, seizures or heart failure (hypertensive emergency)
- Markedly elevated BP well above the 95th centile
- Signs of coarctation (weak femoral pulses, upper-lower limb BP gradient)
- Oliguria/rising creatinine (renovascular/renal disease)
- Rapid BP fall from treatment
Assessment
Differential diagnosis
- Renovascular (renal artery thrombosis/stenosis, often post-UAC)
- Renal parenchymal disease (polycystic kidneys, obstructive uropathy, ATN)
- Coarctation of the aorta
- Endocrine (congenital adrenal hyperplasia, hyperthyroidism, hyperaldosteronism)
- Fluid overload / iatrogenic (steroids, inotropes, caffeine)
- Chronic lung disease-associated hypertension
Investigations
- Confirm with an appropriately sized cuff and gestation/age-specific BP centiles; measure in all four limbs
- U&E, creatinine, and urinalysis
- Renal tract ultrasound with Doppler (renal vessels, kidneys, thrombus)
- Echocardiography (coarctation, left ventricular function/hypertrophy)
- Plasma renin, aldosterone and thyroid function; consider cortisol/metanephrines if indicated
- Review umbilical catheter history and current medications
Management
- Confirm genuine, sustained hypertension with correct technique and age-specific centiles before treating
- Remove reversible contributors — review fluids, pain, inotropes, steroids and umbilical lines
- Investigate for an underlying cause (renal Doppler ultrasound, echocardiography, endocrine screen)
- For asymptomatic mild hypertension, monitor closely and treat the cause
- For significant sustained hypertension, start an oral antihypertensive and titrate
- For severe/symptomatic hypertension or end-organ signs, use a titratable continuous IV infusion in a monitored setting
- Lower blood pressure gradually (over hours-days) to avoid cerebral ischaemia/haemorrhage
- Avoid ACE inhibitors in the very young/renovascular disease and where renal function is a concern
- Reassess for secondary causes amenable to specific treatment (e.g. obstruction, coarctation)
- Involve nephrology/cardiology and arrange ongoing blood pressure monitoring and follow-up
Drugs & doses
Nicardipine IV infusion 0.5-1 microgram/kg/min, titrate (severe/monitored) — or labetalol infusion 0.25-1 mg/kg/h
Hydralazine 0.1-0.5 mg/kg/dose IV (acute) or oral for moderate hypertension
Amlodipine 0.05-0.3 mg/kg/day PO (maintenance, titrate)
Propranolol 0.25-1 mg/kg/dose PO every 8 h (avoid in chronic lung disease/bronchospasm); use ACE inhibitors (e.g. captopril) cautiously and not first-line in neonates
Disposition
Neonatal unit management with nephrology/cardiology input; monitored IV therapy for emergencies. Arrange outpatient blood-pressure surveillance and treat the underlying cause.
Complications & pitfalls
- Hypertensive encephalopathy and intracranial haemorrhage
- Cardiac failure and left ventricular hypertrophy
- Renal impairment
- Cerebral ischaemia from over-rapid lowering
- End-organ damage if untreated
Exam pearls
- Always confirm with the right cuff size and age-specific centiles before labelling a neonate hypertensive
- Think renovascular thromboembolism after umbilical arterial catheterisation
- Reduce blood pressure gradually; abrupt drops risk cerebral injury
- Avoid ACE inhibitors as first-line in neonates, especially with impaired renal function or renovascular disease
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.